TRACON Pharmaceuticals (TCON)
(Delayed Data from NSDQ)
$1.81 USD
+0.02 (1.12%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.80 -0.01 (-0.55%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TCON 1.81 +0.02(1.12%)
Will TCON be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for TCON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TCON
Tracon (TCON) Moves to Buy: Rationale Behind the Upgrade
TCON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TCON
INVO, EZGO and WISA among pre-market losers
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday